Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cryosa

Request full access

Medical device company developing novel treatments for obstructive sleep apnea

Arden Hills, United StatesFounded 2018Health Tech & Medtech

About Cryosa

Cryosa, Inc. is a clinical-stage company focused on developing innovative treatments for moderate to severe Obstructive Sleep Apnea (OSA). The company operates in the medical technology sector and targets patients suffering from OSA, a condition characterized by repeated interruptions in breathing during sleep. Cryosa's proprietary technology offers a minimally invasive, incisionless solution that leverages a controlled cooling process to reduce tissue and open airways, eliminating the need for masks, hoses, or implants. The business model revolves around clinical trials, regulatory approvals, and eventual commercialization of their treatment. Revenue generation is anticipated through the sale of their medical devices and associated therapies once they receive market approval. Cryosa has successfully raised $8.25 million in Series A-2 funding to further develop their breakthrough treatment. The company is currently enrolling participants in a U.S. pilot study, ARCTIC 3, to evaluate the safety and effectiveness of their therapy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
13
Open positions
None listed
Dealroom signal
66.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Surgery, Respiratory, Pulmonary, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Sep 2021 $22M $86M Sante Ventures · HOYA CORPORATION · Solas BioVentures —
SERIES A✓Equity / VC Jun 2020 $8.3M $33M HOYA CORPORATION · Sante Ventures —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cryosa website traffic

Latest recorded traffic for Cryosa is 1.8K monthly website visits, up 0% over the last three months. Cryosa's team declined 18.8% over the past year.

Latest monthly visits1.8K 3-month web change0% 1-year team growth-18.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cryosa in the Arden Hills ecosystem

Live from Dealroom

The Cryosa office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Sante Ventures
  • HOYA CORPORATION
  • Solas BioVentures

Other known investors2 additional known investors

  • Brightstone Venture Capital
  • Gravity Fund
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Cryosa’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.